ITS 2012 Report – Nutrition and gut immunity – Are we eating the enemy?
by Maria Dalby – It is possible to modulate the body’s immune system by altering the gut microbiota, simply by changing the diet.
by Maria Dalby – It is possible to modulate the body’s immune system by altering the gut microbiota, simply by changing the diet.
by Maria Dalby – Introduction – In many ways waiting lists to receive an organ transplantation look very much the same today as they did a decade ago… read more.
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a… read more.
Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths.
The routine use of non-steroidal anti-inflammatory drugs (NSAIDs) among patients with ankylosing spondylitis can slow the progression of bone changes in the spine, two groups of European researchers… read more.
by Thomas R. Collins – A method for cross-matching organ donors and recipients — using beads and human complement — is producing more reliable results, making for transplantation of hearts… read more.
by Gary Finnegan – World Health Matters (South Korea) – Stem cells could be used to restore neuron function to parts of the brain damaged by Huntington’s disease… read more.
by Thomas R. Collins – Stereotactic body radiation therapy (SBRT), or radiosurgery, is effective in treating hepatocellular cancer (HCC) tumours that are unresectable and it can act as… read more.
Mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder appear to be highly associated with non-medical prescription opioid use.
by Dr Sunil Upadhyay – The role of bisphosphonates in the management of breast cancer with bone metastases is well established. However, their benefit in the adjuvant setting… read more.
by Dr Sunil Upadhyay – The majority of breast cancer patients diagnosed with oestrogen receptor positive tumours respond well to endocrine therapy like tamoxifen and aromatase inhibitors, when… read more.
by Dr Sunil Upadhyay – We know that atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in-situ (LCIS) and borderline DCIS/severe ADH are breast lesions which… read more.